AI设计药物早期试验显示可逆转生物衰老标志
AI-designed drug appears to turn back the body's biological clock in early trial
A study in Nature Biotechnology suggests that rentosertib, a drug designed with AI by Insilico Medicine, may reverse markers of biological aging. Six independent aging clocks predicted that treated patients were biologically up to six years younger than the placebo group. The trial covered just 42 patients and the drug hasn't been tested in healthy people yet.
The article AI-designed drug appears to turn back the body's biological clock in early trial appeared first on The Decoder.
更进一步：量化金融体系
看懂新闻只是起点——沿量化金融路径，把它变成能交付的工程能力